HEATHER SILVA: Open Payments
NPI 1649265976 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 20 payments from 8 companies in 2025. Trend: 2023 $484 · 2024 $757 · 2025 $723
Food & beverage: $623Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 2 | $236 |
| Arcutis Biotherapeutics, Inc. | 6 | $129 |
| GENZYME CORPORATION | 3 | $97 |
| UCB, Inc. | 3 | $77 |
| Lilly USA, LLC | 2 | $60 |
| ABBVIE INC. | 2 | $52 |
| MIMEDX Group, Inc. | 1 | $43 |
| Amgen Inc. | 1 | $29 |
Products named: TREMFYA, Zoryve, DUPIXENT, Bimzelx, EBGLYSS, TALTZ, Otezla, RINVOQ.
Industry payments across CA — which companies pay providers there.
